BlackRock Fund Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.45M Buy
5,359
+1,217
+29% +$290K ﹤0.01% 3200
2016
Q3
$920K Buy
4,142
+318
+8% +$89.2K ﹤0.01% 3232
2016
Q2
$1.48M Buy
3,824
+3,498
+1,073% +$3.82M ﹤0.01% 3231
2016
Q1
$220K Sell
326
-24
-7% -$16.2K ﹤0.01% 3425
2015
Q4
$367K Buy
350
+17
+5% +$16.8K ﹤0.01% 3332
2015
Q3
$289K Sell
333
-58
-15% -$48.5K ﹤0.01% 3355
2015
Q2
$278K Sell
391
-3,449
-90% -$3.67M ﹤0.01% 3399
2015
Q1
$8.67M Sell
3,840
-1
-0% -$1.71K ﹤0.01% 2521
2014
Q4
$3.95M Buy
3,841
+533
+16% +$570K ﹤0.01% 2993
2014
Q3
$3.5M Buy
3,308
+1
+0% +$1.68K ﹤0.01% 2949
2014
Q2
$8.28M Sell
3,307
-220
-6% -$449K ﹤0.01% 2534
2014
Q1
$6.72M Buy
3,527
+709
+25% +$1.68M ﹤0.01% 2638
2013
Q4
$6.03M Buy
2,818
+198
+8% +$468K ﹤0.01% 2692
2013
Q3
$5.89M Buy
2,620
+299
+13% +$578K ﹤0.01% 2688
2013
Q2
$4.02M Buy
+2,321
New +$3.68M ﹤0.01% 2839

Other funds holding AMPE

BlackRock Fund Advisors's AMPE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Ampio Pharmaceuticals Inc. (AMPE) stake by 29% in Q4 2016, buying an estimated $290K and bringing the position to 5,359 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3200.

BlackRock Fund Advisors first reported a position in AMPE in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.67M in Q1 2015. 71 funds tracked by Wall St. Rank hold AMPE as of Q4 2016.

  • BlackRock Fund Advisors held 5,359 shares of Ampio Pharmaceuticals Inc. worth $1.45M as of Q4 2016.
  • BlackRock Fund Advisors bought 1,217 Ampio Pharmaceuticals Inc. shares in Q4 2016, an estimated $290K.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3200 holding.
  • BlackRock Fund Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Ampio Pharmaceuticals Inc. position peaked at $8.67M in Q1 2015.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.